Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history - PubMed (original) (raw)
Observational Study
. 2016 Feb 7;37(6):561-7.
doi: 10.1093/eurheartj/ehv462. Epub 2015 Sep 20.
Affiliations
- PMID: 26392438
- PMCID: PMC4744619
- DOI: 10.1093/eurheartj/ehv462
Observational Study
Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history
Hayato Tada et al. Eur Heart J. 2016.
Abstract
Aims: Genetic risk scores (GRSs) have been associated with coronary heart disease (CHD) in large studies. We asked whether expanding an established 27-variant GRS (GRS27) to a 50-variant GRS (GRS50) improved CHD prediction and whether GRSs are independent of self-reported family history of CHD.
Methods and results: The association between GRSs and incident CHD was assessed in Cox models adjusting for established risk factors in 23 595 participants of the Malmö Diet and Cancer study--a prospective, population-based study. During a median follow-up of 14.4 years, 2213 participants experienced a first CHD event. After adjustment for established risk factors, both GRS27 and GRS50 were associated with incident CHD [hazard ratio (HR) = 1.70 for high (top quintile) vs. low (bottom quintile) of GRS27; 95% confidence interval (CI): 1.48-1.94; Ptrend = 1.6 × 10(-15) and HR = 1.92 for GRS50; 95% CI: 1.67-2.20; Ptrend = 6.2 × 10(-22)]. Adding 23 single nucleotide polymorphisms (SNPs) to GRS27 improved risk prediction (P = 3 × 10(-6)). Further adjustment for self-reported family history did not appreciably change the risk estimates of either GRS27 (HR = 1.65; 95% CI: 1.45-1.89) or GRS50 (HR = 1.87; 95% CI: 1.63-2.14). The addition of GRS50 to established risk factors, including self-reported family history, improved discrimination (P < 0.0001) and reclassification (continuous net reclassification improvement index = 0.17, P < 0.0001). In young participants (below median age), those with high GRS50 had 2.4-fold greater risk (95% CI: 1.85-3.12) than those with low GRS50.
Conclusion: The addition of 23 SNPs to an existing GRS27 improved CHD risk prediction and was independent of self-reported family history. Coronary heart disease risk assessment by GRS could be particularly useful in young individuals.
Keywords: Coronary heart disease risk; Genetic risk scores.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures
Figure 1
Cumulative incidence of coronary heart disease events according to self-reported family history of coronary heart disease and 50-variant genetic risk score. Blue and green: those with high 50-variant genetic risk score with (blue) or without (green) a self-reported family history. Red and black: those with low 50-variant genetic risk score with (red) or without (black) a self-reported family history. Inset: those with intermediate 50-variant genetic risk score with (dashed) or without (dotted) a self-reported family history. FH, self-reported family history. Cumulative incidence was estimated while considering non-coronary heart disease death as competing risk. (A) Participants younger than median age (≤57.6). Median age for this younger group is 51.4 (interquartile range, 48.8–54.2). (B) Participants older than median age (>57.6). Median age for this older group is 64.7 (interquartile range, 61.1–67.7).
Comment in
- Family or SNPs: what counts for hereditary risk of coronary artery disease?
Schunkert H. Schunkert H. Eur Heart J. 2016 Feb 7;37(6):568-71. doi: 10.1093/eurheartj/ehv545. Epub 2015 Oct 15. Eur Heart J. 2016. PMID: 26475834 No abstract available.
Similar articles
- Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study.
de Vries PS, Kavousi M, Ligthart S, Uitterlinden AG, Hofman A, Franco OH, Dehghan A. de Vries PS, et al. Int J Epidemiol. 2015 Apr;44(2):682-8. doi: 10.1093/ije/dyv070. Epub 2015 May 6. Int J Epidemiol. 2015. PMID: 25953786 - Metabolic Mediators of the Effects of Family History and Genetic Risk Score on Coronary Heart Disease-Findings From the Malmö Diet and Cancer Study.
Fritz J, Shiffman D, Melander O, Tada H, Ulmer H. Fritz J, et al. J Am Heart Assoc. 2017 Mar 20;6(3):e005254. doi: 10.1161/JAHA.116.005254. J Am Heart Assoc. 2017. PMID: 28320750 Free PMC article. - Association between parental history and genetic risk scores for coronary heart disease prediction: The population-based CoLaus study.
Antiochos P, Marques-Vidal P, McDaid A, Waeber G, Vollenweider P. Antiochos P, et al. Atherosclerosis. 2016 Jan;244:59-65. doi: 10.1016/j.atherosclerosis.2015.10.104. Epub 2015 Nov 3. Atherosclerosis. 2016. PMID: 26584140 - The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S, Liu L, Zhuge QC, Yu Z, Zhang X, Xie J, Hong W, Wang S, Yang Y, Chen B. Ding S, et al. Wien Klin Wochenschr. 2012 Oct;124(19-20):671-7. doi: 10.1007/s00508-012-0223-0. Epub 2012 Sep 18. Wien Klin Wochenschr. 2012. PMID: 22987045 Review. - Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y, Li P, Zhang J, Shi Y, Chen K, Yang J, Wu Y, Ye X. Qian Y, et al. Medicine (Baltimore). 2016 Aug;95(32):e4299. doi: 10.1097/MD.0000000000004299. Medicine (Baltimore). 2016. PMID: 27512842 Free PMC article. Review.
Cited by
- Coronary Artery Disease, Family History, and Screening Perspectives: An Up-to-Date Review.
Di Lenarda F, Balestrucci A, Terzi R, Lopes P, Ciliberti G, Marchetti D, Schillaci M, Doldi M, Melotti E, Ratti A, Provera A, Paolisso P, Andreini D, Conte E. Di Lenarda F, et al. J Clin Med. 2024 Sep 30;13(19):5833. doi: 10.3390/jcm13195833. J Clin Med. 2024. PMID: 39407893 Free PMC article. Review. - Differential prediction performance between Caribbean- and Mainland-subgroups using state-of-the-art polygenic risk scores for coronary heart disease: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Hutten CG, Boehm FJ, Smith JA, Spitzer BW, Wassertheil-Smoller S, Isasi CR, Cai J, Unkart JT, Sun J, Persky V, Daviglus ML, Sofer T, Argos M. Hutten CG, et al. medRxiv [Preprint]. 2024 Sep 27:2024.09.25.24313663. doi: 10.1101/2024.09.25.24313663. medRxiv. 2024. PMID: 39399039 Free PMC article. Preprint. - Polygenic Risk Scores: The Next Step for Improved Risk Stratification in Coronary Artery Disease?
Stein R, Ferrari F, García-Giustiniani D. Stein R, et al. Arq Bras Cardiol. 2024 Sep;121(9):e20240252. doi: 10.36660/abc.20240252. Arq Bras Cardiol. 2024. PMID: 39352188 Free PMC article. Review. English, Portuguese. - Genetic Risk Score for Prediction of Coronary Heart Disease in the Korean Genome and Epidemiology Study.
Yun H, Lim JE, Lee EY. Yun H, et al. Rev Cardiovasc Med. 2023 Apr 4;24(4):102. doi: 10.31083/j.rcm2404102. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076255 Free PMC article. - Polygenic Risk, Rare Variants, and Family History: Independent and Additive Effects on Coronary Heart Disease.
Saadatagah S, Naderian M, Dikilitas O, Hamed ME, Bangash H, Kullo IJ. Saadatagah S, et al. JACC Adv. 2023 Aug 26;2(7):100567. doi: 10.1016/j.jacadv.2023.100567. eCollection 2023 Sep. JACC Adv. 2023. PMID: 38939477 Free PMC article.
References
- Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 2012. Brussels/Sophia Antipolis: European Heart Network/European Society of Cardiology; 2012.
- Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014;129:e28–e292. - PMC - PubMed
- Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635–1701. - PubMed
- Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson J, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014;63:2935–2959. - PMC - PubMed
- Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, Levy D, Murabito JM, Wang TJ, Wilson PW, O'Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004;291:2204–2211. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical